Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma.

Chuan LiZhi-Cheng LiLiang MaLe-Qun LiJian-Hong ZhongBang-De XiangWen-Feng Gong

Published in: Expert review of gastroenterology & hepatology (2020)

Perioperative antiviral therapy can significantly reduce the risk of HBV reactivation and improve postoperative liver function, RFS and OS.

Keyphrases